Patient characteristics
| Control patients (n = 26) | |
| Age (median), y | 3-68 (52) |
| Donor type | Unrelated 16, related 10 |
| HLA-match | Matched 21, mismatched 5 |
| Conditioning regimens* | Full intensity 8, reduced intensity 18 |
| Day of duodenal biopsy (median) | |
| Asymptomatic screening patients | 20-30 (26) |
| Chronic GVHD work-up | 133-882 (246) |
| Non-GVHD enteritis | 31-163 (37) |
| GI GVHD patients (n = 116) | |
| Age (median), y | 9-67 (52) |
| Donor type | Unrelated 70, related 40 |
| HLA-match | Matched 85, mismatched 31 |
| Conditioning regimens* | Full intensity 58, reduced intensity 58 |
| GI GVHD onset (median), d | 10-282 (37) |
| Day of duodenal biopsy (median) | 11-290 (40) |
| Control patients (n = 26) | |
| Age (median), y | 3-68 (52) |
| Donor type | Unrelated 16, related 10 |
| HLA-match | Matched 21, mismatched 5 |
| Conditioning regimens* | Full intensity 8, reduced intensity 18 |
| Day of duodenal biopsy (median) | |
| Asymptomatic screening patients | 20-30 (26) |
| Chronic GVHD work-up | 133-882 (246) |
| Non-GVHD enteritis | 31-163 (37) |
| GI GVHD patients (n = 116) | |
| Age (median), y | 9-67 (52) |
| Donor type | Unrelated 70, related 40 |
| HLA-match | Matched 85, mismatched 31 |
| Conditioning regimens* | Full intensity 58, reduced intensity 58 |
| GI GVHD onset (median), d | 10-282 (37) |
| Day of duodenal biopsy (median) | 11-290 (40) |
HLA, human leukocyte antigen.
Details of the conditioning regimens are provided in supplemental Table 1.